Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios

Yevgeniy Goryakin, Sophie Thiébaut, Sébastien Cortaredona (sebastien.cortaredona@inserm.fr), M. Aliénor Lerouge, Michele Cecchini, Andrea Feigl and Bruno Ventelou
Additional contact information
Sophie Thiébaut: Imperial College London
Sébastien Cortaredona: AMSE - Aix-Marseille Sciences Economiques - EHESS - École des hautes études en sciences sociales - AMU - Aix Marseille Université - ECM - École Centrale de Marseille - CNRS - Centre National de la Recherche Scientifique
M. Aliénor Lerouge: OCDE - Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development
Michele Cecchini: OCDE - Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development
Andrea Feigl: OCDE - Organisation de Coopération et de Développement Economiques = Organisation for Economic Co-operation and Development

Post-Print from HAL

Abstract: Background: Ageing populations and rising prevalence of non-communicable diseases (NCDs) increasingly contribute to the growing cost burden facing European healthcare systems. Few studies have attempted to quantify the future magnitude of this burden at the European level, and none of them consider the impact of potential changes in risk factor trajectories on future health expenditures. Methods: The new microsimulation model forecasts the impact of behavioural and metabolic risk factors on NCDs, longevity and direct healthcare costs, and shows how changes in epidemiological trends can modify those impacts. Economic burden of NCDs is modelled under three scenarios based on assumed future risk factors trends: business as usual (BAU); best case and worst case predictions (BCP and WCP). Findings: The direct costs of NCDs in the EU 27 countries and the UK (in constant 2014 prices) will grow under all scenarios. Between 2014 and 2050, the overall healthcare spending is expected to increase by 0.8% annually under BAU. In the all the countries, 605 billion Euros can be saved by 2050 if BCP is realized compared to the BAU, while excess spending under the WCP is forecast to be around 350 billion. Interpretation: Although the savings realised under the BCP can be substantial, population ageing is a stronger driver of rising total healthcare expenditures in Europe compared to scenario-based changes in risk factor prevalence.

Keywords: Health economics; Europe; Medical risk factors; European Union; Noncommunicable diseases; Cancer risk factors; Cardiovascular disease risk; Obesity (search for similar items in EconPapers)
Date: 2020-09
New Economics Papers: this item is included in nep-age and nep-for
Note: View the original document on HAL open archive server: https://amu.hal.science/hal-02964995
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Published in PLoS ONE, 2020, 15 (9), pp.e0238565. ⟨10.1371/journal.pone.0238565⟩

Downloads: (external link)
https://amu.hal.science/hal-02964995/document (application/pdf)

Related works:
Journal Article: Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios (2020)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-02964995

DOI: 10.1371/journal.pone.0238565

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD (hal@ccsd.cnrs.fr).